Autolus Therapeutics (AUTL) News Today $2.47 -0.01 (-0.40%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.49 +0.02 (+0.81%) As of 07/11/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AUTL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Autolus Therapeutics (NASDAQ:AUTL) Stock, Earnings Estimates, EPS, And Revenue - BenzingaJune 30, 2025 | benzinga.comAutolus Therapeutics Ltd (AUTL) Stock Forums - Investing.comJune 29, 2025 | investing.comAutolus Therapeutics (AUTL) Presents Positive Long-Term Obe-cel Data at EHA 2025June 29, 2025 | msn.comAutolus Therapeutics plc (AUTL) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comNeedham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10June 24, 2025 | msn.comAutolus Therapeutics (NASDAQ:AUTL) Trading 7.1% Higher - Should You Buy?June 23, 2025 | marketbeat.comBank of America Corp DE Reduces Stake in Autolus Therapeutics plc (NASDAQ:AUTL)June 17, 2025 | marketbeat.comWhat 4 Analyst Ratings Have To Say About Autolus TherapeuticsJune 13, 2025 | benzinga.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Down - Time to Sell?June 13, 2025 | marketbeat.comNeedham & Company LLC Reaffirms "Buy" Rating for Autolus Therapeutics (NASDAQ:AUTL)June 12, 2025 | marketbeat.comAutolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) CongressJune 12, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Trading Down 3.2% - Time to Sell?June 11, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Grows Stock Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)June 8, 2025 | marketbeat.comAutolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune MarketJune 6, 2025 | seekingalpha.comAutolus Therapeutics (NASDAQ:AUTL) Shares Gap Up - Here's WhyJune 4, 2025 | marketbeat.comAutolus Therapeutics (NASDAQ:AUTL) Shares Up 10% - What's Next?June 3, 2025 | marketbeat.comTwo Sigma Investments LP Buys 174,485 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)June 2, 2025 | marketbeat.comWellington Management Group LLP Acquires 1,125,454 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)May 31, 2025 | marketbeat.comMillennium Management LLC Grows Stake in Autolus Therapeutics plc (NASDAQ:AUTL)May 31, 2025 | marketbeat.comAutolus Therapeutics to Participate in Upcoming Investor ConferencesMay 29, 2025 | globenewswire.comCetera Investment Advisers Increases Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)May 26, 2025 | marketbeat.comAutolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute ...May 25, 2025 | morningstar.comMAutolus Therapeutics Receives Positive CHMP Opinion for Obecabtagene Autoleucel in Treating Adult Patients with Relapsed or Refractory B-ALLMay 25, 2025 | nasdaq.com247,089 Shares in Autolus Therapeutics plc (NASDAQ:AUTL) Bought by Point72 Asset Management L.P.May 25, 2025 | marketbeat.comAutolus Therapeutics gets EU endorsement for leukemia treatmentMay 23, 2025 | msn.comAutolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment BrightensMay 23, 2025 | msn.comAutolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)May 23, 2025 | globenewswire.comAutolus Therapeutics plc (AUTL): Analysts See 697% Upside PotentialMay 20, 2025 | insidermonkey.comTFG Asset Management GP Ltd Buys 250,000 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)May 20, 2025 | marketbeat.comAutolus Therapeutics Announces Upcoming Presentations at the European Hematology Association Congress 2025May 16, 2025 | nasdaq.comAutolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) CongressMay 14, 2025 | globenewswire.comAutolus Therapeutics (NASDAQ:AUTL) Issues Quarterly Earnings ResultsMay 12, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Receives Consensus Rating of "Buy" from AnalystsMay 12, 2025 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Vericel (VCEL), Autolus Therapeutics (AUTL) and Pacira Pharmaceuticals (PCRX)May 11, 2025 | theglobeandmail.comAutolus Therapeutics plc (AUTL) Q1 2025 Earnings Call TranscriptMay 11, 2025 | seekingalpha.comAxa S.A. Makes New Investment in Autolus Therapeutics plc (NASDAQ:AUTL)May 10, 2025 | marketbeat.comAutolus Therapeutics plc 2025 Q1 - Results - Earnings Call PresentationMay 9, 2025 | seekingalpha.comAutolus Therapeutics PLC (AUTL) Q1 2025 Earnings Call Highlights: Strong US Launch and ...May 9, 2025 | finance.yahoo.comDeep Track Capital LP Cuts Holdings in Autolus Therapeutics plc (NASDAQ:AUTL)May 9, 2025 | marketbeat.comAutolus Therapeutics Reports First Quarter 2025 Financial Results and Business UpdatesMay 8, 2025 | globenewswire.comPrice T Rowe Associates Inc. MD Sells 902,261 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)May 6, 2025 | marketbeat.comAutolus Therapeutics (AUTL) Projected to Post Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comAutolus Therapeutics plc (NASDAQ:AUTL) Stake Boosted by Renaissance Technologies LLCApril 30, 2025 | marketbeat.comLegal & General Group Plc Buys 237,224 Shares of Autolus Therapeutics plc (NASDAQ:AUTL)April 30, 2025 | marketbeat.comWalleye Capital LLC Trims Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL)April 29, 2025 | marketbeat.comAutolus Therapeutics’ obecabtagene autoleucel conditionally approved by MHRAApril 27, 2025 | markets.businessinsider.comQ1 Earnings Estimate for AUTL Issued By William BlairApril 27, 2025 | marketbeat.comAutolus Therapeutics confirms license of Aucatzyl issued by U.K. MHRAApril 26, 2025 | finance.yahoo.comUK approves Autolus leukemia therapy with conditionsApril 26, 2025 | investing.comAutolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)April 25, 2025 | globenewswire.com Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address AUTL Media Mentions By Week AUTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUTL News Sentiment▼1.890.99▲Average Medical News Sentiment AUTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUTL Articles This Week▼14▲AUTL Articles Average Week Get Autolus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AUTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ImmunityBio News Today Arrowhead Pharmaceuticals News Today Apellis Pharmaceuticals News Today NewAmsterdam Pharma News Today Twist Bioscience News Today Denali Therapeutics News Today Kiniksa Pharmaceuticals International News Today Agios Pharmaceuticals News Today Recursion Pharmaceuticals News Today CG Oncology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUTL) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Autolus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AUTL Stock Alerts